Achieve Life Sciences, Inc.

ACHV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $20.9M $12.8M $15.5M $24.8M $43.0M $35.9M $16.7M $9.5M
Accounts Receivable — — — — — — $8.0K $7.0K
Inventory — — — — — — — —
Total Current Assets $39.9M $36.5M $17.0M $27.3M $44.6M $37.0M $17.3M $15.5M
Property, Plant & Equipment $3.0K $8.0K $13.0K $4.0K $15.0K $42.0K $57.0K $35.0K
Goodwill $1.0M $1.0M $1.0M $1.0M $1.0M $1.0M $1.0M $1.0M
Intangible Assets (Excl. Goodwill) $751.0K $974.0K $1.2M $1.4M $1.6M $1.9M $2.1M $2.3M
Total Assets $41.8M $38.6M $19.4M $30.0M $47.5M $40.3M $21.1M $19.1M
Liabilities
Accounts Payable — $2.0M $618.0K $1.7M $841.0K $332.0K $859.0K $144.0K
Total Current Liabilities $9.1M $6.7M $20.8M $21.6M $4.6M $2.9M $2.9M $3.3M
Long-Term Debt — — — — — — — —
Total Liabilities $20.3M $17.7M $20.8M $21.7M $19.5M $3.0M $3.0M $3.3M
Stockholders' Equity
Retained Earnings $-260.2M $-205.6M $-165.8M $-135.9M $-93.6M $-60.4M $-45.7M $-25.4M
Total Stockholders' Equity $21.5M $20.9M $-1.4M $8.3M $28.0M $37.3M $18.1M $15.8M
← Newer Page 1 of 2 Older →